World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
51
Citations
12438
World Ranking
5163
National Ranking
2841

Overview

Joy M. Schmitz is affiliated with The University of Texas Health Science Center at Houston in the United States. Their work spans multiple fields of study including Medicine, Psychology, and Neuroscience, with publication counts of 110, 49, and 47 respectively. Within these broad areas, Schmitz's research often focuses on subfields such as Epidemiology, Clinical Psychology, Cognitive Neuroscience, Cellular and Molecular Neuroscience, and Pharmacology.

The scientist has contributed extensively to research on topics that cover Neurotransmitter Receptor Influence on Behavior, Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, Cannabis and Cannabinoid Research, Posttraumatic Stress Disorder Research, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, and HIV, Drug Use, Sexual Risk.

Joy M. Schmitz has coauthored many publications with several frequent collaborators, including:

  • Scott D. Lane
  • Robert Suchting
  • Heather E. Webber
  • Constanza de Dios
  • Jin H. Yoon

The researcher's work is published in numerous academic venues. The most frequent include:

  • Drug and Alcohol Dependence
  • Experimental and Clinical Psychopharmacology
  • Journal of Addiction Medicine
  • Biological Psychiatry
  • Nicotine & Tobacco Research

Among recent papers authored or coauthored by Schmitz are:

  • "Bupropion and Naltrexone in Methamphetamine Use Disorder" (2021), published in New England Journal of Medicine
  • "Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial" (2021), published in Nicotine & Tobacco Research
  • "A meta-analysis of tract-based spatial statistics studies examining white matter integrity in cocaine use disorder" (2020), published in Addiction Biology
  • "Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation" (2020), published in Clinical Psychopharmacology and Neuroscience
  • "White matter deficits in cocaine use disorder: convergent evidence from in vivo diffusion tensor imaging and ex vivo proteomic analysis" (2021), published in Translational Psychiatry

Best Publications

  • Psychiatric aspects of impulsivity

    F. Gerard Moeller;Ernest S. Barratt;Donald M. Dougherty;Joy M. Schmitz

  • The impact of impulsivity on cocaine use and retention in treatment

    F.Gerard Moeller;Donald M. Dougherty;Ernest S. Barratt;Joy M. Schmitz

  • Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids

    G J Dehmer;J J Popma;E K van den Berg;E J Eichhorn

  • Dextroamphetamine for cocaine-dependence treatment : A double-blind randomized clinical trial

    John Grabowski;Howard Rhoades;Joy Schmitz;Angela Stotts

  • Motivational interviewing with cocaine-dependent patients: A pilot study.

    Angela L. Stotts;Joy M. Schmitz;Howard M. Rhoades;John Grabowski

  • Replacement medication for cocaine dependence: methylphenidate.

    John Grabowski;John D. Roache;Joy M. Schmitz;Howard Rhoades

  • Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

    John Grabowski;Howard Rhoades;Angela L Stotts;Katherine Cowan

  • Bupropion and Naltrexone in Methamphetamine Use Disorder

    Madhukar H Trivedi;Robrina Walker;Walter Ling;Adriane Dela Cruz

  • Fluoxetine Is Ineffective for Treatment of Cocaine Dependence or Concurrent Opiate and Cocaine Dependence: Two Placebo-controlled, Double-blind Trials

    John Grabowski;Howard Rhoades;Ronith Elk;Joy Schmitz

  • Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency

    Howard M. Rhoades;Dan Creson;Ronith Elk;Joy Schmitz

  • Naltrexone and relapse prevention treatment for cocaine-dependent patients

    Joy M Schmitz;Angela L Stotts;Howard M Rhoades;John Grabowski

  • Relationship between impulsivity and decision making in cocaine dependence

    Kimberly L. Kjome;Scott D. Lane;Joy M. Schmitz;Charles Green

  • Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.

    Joy M Schmitz;Patricia Averill;Angela L Stotts;F.Gerard Moeller

  • Risperidone for the treatment of cocaine dependence: Randomized, double- blind trial

    John Grabowski;Howard Rhoades;Peter Silverman;Joy M. Schmitz

  • Determining predictors of attrition in an outpatient substance abuse program.

    Shelly L. Sayre;Joy M. Schmitz;Angela L. Stotts;Patricia M. Averill

  • Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.

    Marc E. Mooney;David V. Herin;Joy M. Schmitz;Nidal Moukaddam

  • Behavioral and emotional problems among children of cocaine- and opiate-dependent parents.

    Catherine Stanger;Stephen T. Higgins;Warren K. Bickel;Ronith Elk

  • Citalopram combined with behavioral therapy reduces cocaine use: A double-blind, placebo-controlled trial

    F. Gerard Moeller;Joy M. Schmitz;Joel L. Steinberg;Charles M. Green

  • Relationship between attentional bias to cocaine-related stimuli and impulsivity in cocaine-dependent subjects.

    Shijing Liu;Scott D. Lane;Joy M. Schmitz;Andrew J. Waters

  • Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

    Joy M. Schmitz;Marc E. Mooney;F. Gerard Moeller;Angela L. Stotts

Frequent Co-Authors

Scott D. Lane
Scott D. Lane The University of Texas Health Science Center at Houston
F. Gerard Moeller
F. Gerard Moeller Virginia Commonwealth University
Howard M. Rhoades
Howard M. Rhoades The University of Texas Health Science Center at Houston
Joel L. Steinberg
Joel L. Steinberg Virginia Commonwealth University
Rodrigo Grassi-Oliveira
Rodrigo Grassi-Oliveira Pontifical Catholic University of Rio Grande do Sul
Paul R. Swank
Paul R. Swank The University of Texas Health Science Center at Houston
Annette L. Stanton
Annette L. Stanton University of California, Los Angeles
Zhongming Zhao
Zhongming Zhao The University of Texas Health Science Center at Houston
Jeffrey S. Kreutzer
Jeffrey S. Kreutzer Virginia Commonwealth University
Ernest S. Barratt
Ernest S. Barratt The University of Texas Medical Branch at Galveston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a psychology degree in the USA opens doors to a wide array of rewarding career opportunities, including fields like speech-language pathology. For those drawn to helping individuals overcome communication and swallowing disorders, both traditional and online degrees can provide a solid foundation for entering this growing sector.

The pathway to becoming a licensed professional varies by state. For example, becoming a speech therapist in Washington requires a master's degree, completion of clinical experience, and passing a national examination. Meanwhile, the slp requirements in West Virginia emphasize accredited education, supervised practice, and state-specific licensing exams.

Other states have their own unique pathways, such as the slp requirements in Wisconsin, which include professional development and continuing education, or the slp requirements in Wyoming, which highlight background checks and adherence to local regulations.

As you explore online psychology programs, keep in mind the specialized requirements for different states. Researching your state's criteria early will help you chart an efficient course toward your ideal career in psychology or speech-language pathology.

Best Scientists Citing Joy M. Schmitz

Trending Scientists

Recently Published Articles